Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biogen Inc (BIIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 72,412,864
  • Shares Outstanding, K 211,480
  • Annual Sales, $ 11,449 M
  • Annual Income, $ 3,703 M
  • 36-Month Beta 0.72
  • Price/Sales 6.12
  • Price/Cash Flow 14.57
  • Price/Book 5.67

Price Performance

See More
Period Period Low Period High Performance
1-Month
316.25 +9.93%
on 12/26/17
347.82 -0.05%
on 01/22/18
+28.14 (+8.81%)
since 12/22/17
3-Month
301.81 +15.19%
on 10/24/17
347.82 -0.05%
on 01/22/18
+9.54 (+2.82%)
since 10/20/17
52-Week
244.28 +42.31%
on 05/31/17
348.84 -0.34%
on 10/18/17
+89.12 (+34.47%)
since 01/20/17

Most Recent Stories

More News
What's in the Cards for Biogen (BIIB) This Earnings Season?

On the Q4 call, investor focus will be on the impact of Roche's newly launched drug, Ocrevus on Biogen's (BIIB) MS franchise, and Spinraza's performance.

EBS : 50.41 (-1.52%)
RHHBY : 30.7900 (+0.33%)
ALXN : 123.67 (+2.16%)
BIIB : 347.64 (+1.53%)
Sanofi to Acquire Haemophilia Focused Bioverativ, Stock Dips

Sanofi (SNY) is set to acquire blood disorder focused biopharmaceutical company, Bioverativ, for $11.6 billion.

ALNY : 131.00 (+4.94%)
BIVV : 103.79 (+61.89%)
SNY : 43.20 (-3.14%)
BIIB : 347.64 (+1.53%)
Will These 4 Large-Cap Drug Stocks Be Big Winners This Earnings Season?

Here is a look at four large-cap pharma and biotech stocks including Merck (MRK) that could surpass earnings expectations in the fourth quarter.

CELG : 102.91 (+0.25%)
MRK : 61.25 (-0.05%)
ABBV : 106.49 (+1.77%)
JUNO : 86.00 (+26.82%)
SNY : 43.20 (-3.14%)
ALXN : 123.67 (+2.16%)
BIIB : 347.64 (+1.53%)
Watch for Biogen Inc to Potentially Pullback After Gaining 1.04% Yesterday

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $336.56 to a high of $344.87. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $339.94...

BIIB : 347.64 (+1.53%)
3 Pharma and Biotech Stocks to Watch Out for in 2018

Here is a look at three pharma and biotech stocks including Alkermes (ALKS) that look well-positioned for 2018.

XOMA : 33.84 (+0.77%)
NVS : 87.00 (+0.07%)
ALKS : 57.62 (+1.03%)
BIIB : 347.64 (+1.53%)
EIGR : 8.75 (-1.13%)
Roche MS Drug Ocrevus Gets Marketing Authorization in Europe

Roche's (RHHBY) multiple sclerosis drug Ocrevus gets approval in Europe thereby boosting its neuroscience portfolio. The drug is already approved in the United States.

EXEL : 29.44 (+5.14%)
RHHBY : 30.7900 (+0.33%)
MKGAF : 109.2000 (+0.55%)
BIIB : 347.64 (+1.53%)
Top Stock Reports for Home Depot, CVS Health & Biogen

Top Stock Reports for Home Depot, CVS Health & Biogen

GOOGL : 1,164.16 (+1.81%)
CVS : 80.95 (+1.36%)
WDC : 86.24 (+0.75%)
HD : 204.46 (+1.55%)
RTN : 196.37 (-0.16%)
BIIB : 347.64 (+1.53%)
Big Pharma CEOs Speak About Impact of Tax Reform on M&A

This week, senior executives of some large drug companies discussed the impact of tax reform on mergers and acquisition and their plans to use the excess cash at the JP Morgan HealthCare conference.

CELG : 102.91 (+0.25%)
JNJ : 148.14 (+0.53%)
MRK : 61.25 (-0.05%)
LLY : 85.44 (-0.06%)
AGN : 188.15 (+3.76%)
GILD : 81.41 (+0.53%)
BIIB : 347.64 (+1.53%)
Stock Market News For Jan 9, 2018

Markets finished mostly higher on Monday even as safe haven stocks such as utilities and real estate gained traction

NFLX : 227.58 (+3.23%)
GOOGL : 1,164.16 (+1.81%)
LULU : 78.96 (-0.48%)
NVDA : 233.69 (+1.56%)
JPM : 114.33 (+1.17%)
BGFV : 6.20 (+1.64%)
KSS : 68.17 (+0.93%)
FB : 185.37 (+2.25%)
GS : 261.52 (+2.11%)
REGN : 375.86 (+1.17%)
AMZN : 1,327.31 (+2.53%)
BIIB : 347.64 (+1.53%)
Today's Research Reports on Stocks to Watch: Biogen Inc. and Celgene Corporation

NEW YORK, NY / ACCESSWIRE / January 9, 2018 / Biogen shares slipped on Monday after it was revealed that a competitor, AveXis, could have a significant delay in a medicine that could compete against Spinraza....

CELG : 102.91 (+0.25%)
CELGZ : 1.00 (+9.89%)
BIIB : 347.64 (+1.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia,...

See More

Key Turning Points

2nd Resistance Point 351.62
1st Resistance Point 349.63
Last Price 347.64
1st Support Level 343.84
2nd Support Level 340.04

See More

52-Week High 348.84
Last Price 347.64
Fibonacci 61.8% 308.90
Fibonacci 50% 296.56
Fibonacci 38.2% 284.22
52-Week Low 244.28

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.